Gladstone Institutional Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Gladstone Institutional Advisory's BSX Position: Q2 2026 in Review
Gladstone Institutional Advisory reduced its Boston Scientific (BSX) stake by 1.6% in Q2 2026, selling an estimated $12.3K and leaving 13,611 shares worth $581K. The position accounts for 0.02% of the portfolio, ranked #548.
Gladstone Institutional Advisory first reported a position in BSX in Q2 2021 and has held it in 16 quarters since. The position peaked at $5.07M in Q3 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Gladstone Institutional Advisory held 13,611 shares of Boston Scientific worth $581K as of Q2 2026.
- Gladstone Institutional Advisory sold 227 Boston Scientific shares in Q2 2026, an estimated $12.3K.
- Boston Scientific made up 0.02% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #548 holding.
- Gladstone Institutional Advisory first reported a position in Boston Scientific in Q2 2021 and has held it in 16 quarters since.
- Gladstone Institutional Advisory's Boston Scientific position peaked at $5.07M in Q3 2025.
- 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.